HCID 11097971, Verbindung → HCID 10288916, Verbindung

HRID 2219267Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 2219267
[N+:1]([C:4]1[CH:5]=[CH:6][C:7]2[O:12][C@:11]([CH3:18])([CH:13]([O:16][CH3:17])[O:14][CH3:15])[C@@H:10]3[O:19][C@@H:9]3[C:8]=2[CH:20]=1)([O-:3])=[O:2].[CH2:21]([NH:28][CH2:29][C:30]1[N:31]=[N:32][N:33]([CH3:35])[N:34]=1)[C:22]1[CH:27]=[CH:26][CH:25]=[CH:24][CH:23]=1>>[N+:1]([C:4]1[CH:5]=[CH:6][C:7]2[O:12][C@:11]([CH3:18])([CH:13]([O:16][CH3:17])[O:14][CH3:15])[C@H:10]([OH:19])[C@@H:9]([N:28]([CH2:21][C:22]3[CH:27]=[CH:26][CH:25]=[CH:24][CH:23]=3)[CH2:29][C:30]3[N:31]=[N:32][N:33]([CH3:35])[N:34]=3)[C:8]=2[CH:20]=1)([O-:3])=[O:2]

Komponenten

3

Edukt 2

HCID 11097971HCID 11097971, VerbindungHCID 69213675HCID 69213675, Verbindung

Produkt 1

HCID 10288916HCID 10288916, VerbindungAusbeute 48 %

Versuchsvorschrift

The same procedure as step 3 of example 1 was accomplished, except for using epoxide compound (200 mg, 0.71 mmol) obtained in step 1 of example 2 and N-benzyl-N-(2-methyl-2H-tetrazol-5-ylmethyl)amine (145 mg, 0.71 mmol). The crude product was purified by silica gel column chromatography (developing solvent-n-hexane:ethyl acetate=1:2), to give desired compound (165 mg, yield: 48%).

Aufarbeitung

  1. customThe crude product was purified by silica gel column chromatography (developing solvent-n-hexane:ethyl acetate=1:2)

Quellen und Nachweise

ORD-Eintrag
ord-86dc022ebf1d4078a99de19cd2769ba7
Quelldatensatz
uspto-grants-2008_08
Patentnummer
US07414068B2

Notizen zur Reaktion

Wird geladen…